Literature DB >> 10795928

Renal urea transporters. Direct and indirect regulation by vasopressin.

L T Bankir1, M M Trinh-Trang-Tan.   

Abstract

Urea is the most abundant urinary solute and is excreted in urine at a much higher concentration than in other body fluids. Urea concentration is achieved in the kidney through complex urea movements between blood vessels and renal tubules, which involve facilitated urea transport. Three major urea transporters expressed in the kidney have been cloned, UT-A1, UT-A2 and UT-B1, the first two derived from the same gene by differential transcription. These membrane proteins enable facilitated diffusion of urea through specific parts of the nephron (UT-A) and through renal vasculature (UT-B) in the medulla. UT-A1 is localised in the terminal part of the inner medullary collecting ducts and accounts for the vasopressin-dependent increase in urea permeability of this segment. UT-A2 is found in the descending thin limbs of Henle's loops. UT-B1 is expressed in the endothelium of the descending vasa recta supplying blood to the renal medulla, and in red cells. All three urea transporters are primarily involved in the process of intrarenal urea recycling, which enables the establishment, and prevents the dissipation, of a high concentration of urea in the inner medulla. This is an essential feature for producing a concentrated urine and thus for water economy in mammals. Vasopressin, upon binding to V2 receptors in the inner medullary collecting ducts, increases urea permeability through activation of UT-A1 molecules, thus enabling urea to diffuse into the inner medullary interstitium. Urea then taken up in ascending vasa recta is returned to the inner medulla via UT-A2 and UT-B1 by countercurrent exchange. These latter two urea transporters are not influenced acutely by vasopressin, but UT-A2 expression is markedly increased in the descending thin limbs of the loops of Henle after sustained exposure to vasopressin or its V2 agonist dDAVP. This effect is indirect because vasopressin receptors are lacking in the descending limbs. The acute direct and delayed indirect actions of vasopressin on renal urea transporters will increase medullary urea accumulation and thus the ability of the kidney to conserve water. Atrial natriuretic peptide inhibits the vasopressin-dependent increase in urea permeability in the inner medullary collecting ducts. The interruption of urea recycling probably contributes to the natriuresis. Impairing in this way the capacity of the kidney to concentrate urea enhances its capacity to concentrate sodium in the urine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10795928     DOI: 10.1111/j.1469-445x.2000.tb00029.x

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  12 in total

Review 1.  Molecular physiology of urinary concentration defect in elderly population.

Authors:  B K Kishore; C M Kran; M Reif; A G Menon
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  Blood urea nitrogen to creatinine ratio is associated with congestion and mortality in heart failure patients with renal dysfunction.

Authors:  Gaspare Parrinello; Daniele Torres; Jeffrey M Testani; Piero Luigi Almasio; Michele Bellanca; Giuseppina Pizzo; Francesco Cuttitta; Antonio Pinto; Javed Butler; Salvatore Paterna
Journal:  Intern Emerg Med       Date:  2015-06-03       Impact factor: 3.397

3.  Phenylphthalazines as small-molecule inhibitors of urea transporter UT-B and their binding model.

Authors:  Jian-Hua Ran; Min Li; Weng-Ieong Tou; Tian-Luo Lei; Hong Zhou; Calvin Yu-Chian Chen; Bao-Xue Yang
Journal:  Acta Pharmacol Sin       Date:  2016-05-30       Impact factor: 6.150

Review 4.  Urea transporter proteins as targets for small-molecule diuretics.

Authors:  Cristina Esteva-Font; Marc O Anderson; Alan S Verkman
Journal:  Nat Rev Nephrol       Date:  2014-12-09       Impact factor: 28.314

Review 5.  Urine concentration and avian aquaporin water channels.

Authors:  Hiroko Nishimura
Journal:  Pflugers Arch       Date:  2008-02-16       Impact factor: 3.657

Review 6.  Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation.

Authors:  Adriana Marton; Tatsuroh Kaneko; Jean-Paul Kovalik; Atsutaka Yasui; Akira Nishiyama; Kento Kitada; Jens Titze
Journal:  Nat Rev Nephrol       Date:  2020-10-01       Impact factor: 28.314

7.  Tolvaptan promotes urinary excretion of sodium and urea: a retrospective cohort study.

Authors:  Satoshi Minami; Takayuki Hamano; Hirotsugu Iwatani; Masayuki Mizui; Yoshiki Kimura; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2017-10-20       Impact factor: 2.801

8.  Comparison of the effects of tolvaptan and furosemide on renal water and sodium excretion in patients with heart failure and advanced chronic kidney disease: a subanalysis of the K-STAR study.

Authors:  Naoto Tominaga; Keisuke Kida; Takayuki Inomata; Naoki Sato; Tohru Izumi; Yoshihiro J Akashi; Yugo Shibagaki
Journal:  Clin Exp Nephrol       Date:  2018-06-22       Impact factor: 2.801

9.  Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression.

Authors:  Judith E Heida; Ron T Gansevoort; A Lianne Messchendorp; Esther Meijer; Niek F Casteleijn; Wendy E Boertien; Debbie Zittema
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-27       Impact factor: 8.237

10.  Proteasome-dependent degradation of intracellular carbamylated proteins.

Authors:  Aurore Desmons; Anaïs Okwieka; Manon Doué; Laëtitia Gorisse; Vincent Vuiblet; Christine Pietrement; Philippe Gillery; Stéphane Jaisson
Journal:  Aging (Albany NY)       Date:  2019-06-06       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.